Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1
Tóm tắt
Daytime sleepiness and fatigue are prominent symptoms of myotonic dystrophy type I (DM1) that exact a heavy toll on patients’ quality of life, but information is scarce on their predictive factors. This study aimed to determine factors that may influence levels of daytime sleepiness and fatigue in a large cohort of DM1 patients followed for 9 years. This study included 115 patients with DM1 at baseline (Time 1, T1) and at Time 2 (T2) who were questioned for daytime sleepiness, fatigue, history of depression, psychological distress, pain, hypothyroidism, and sleep habits. Also, their muscular impairment and intellectual quotient were evaluated. Regression models were used to identify correlates of daytime sleepiness and fatigue while controlling for time effect. Both daytime sleepiness and fatigue increased between T1 and T2, but their rate of change are higher when CTG repeat number is higher (p < 0.05). Also, higher psychological distress level is associated with higher daytime sleepiness and fatigue levels both at T1 and T2 (p < 0.01). Moreover, patients with a history of depression report higher daytime sleepiness levels both at T1 and T2 (p < 0.05). In addition, patients with higher fatigue levels both at T1 and T2 have more severe muscular impairment (p < 0.01) and report a longer habitual sleep duration (p < 0.05). Finally, a higher BMI and a history of hypothyroidism predict higher daytime sleepiness levels at T2 (p < 0.05). This study identified potentially modifiable risk factors of future daytime sleepiness and fatigue in DM1 patients, including BMI, psychological distress, hypothyroidism, and sleep habits.
Tài liệu tham khảo
Harper PS (2001) Myotonic dystrophy, 3rd edn. W.B. Saunders, Philadelphia
Mathieu J, De Braekeleer M, Prevost C (1990) Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 40:839–842
Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ et al (1992) Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355:545–546
Rohrer K (1916) Ueber myotonia atrophica (dystrophia myotonica). Dtsch Z Nervenheilkd 55:242–304
Ashizawa T (1998) Myotonic dystrophy as a brain disorder. Arch Neurol 55:291–293
Hilton-Jones D (1997) Myotonic dystrophy-forgotten aspects of an often neglected condition. Curr Opin Neurol 10:399–401
Kierkegaard M, Harms-Ringdahl K, Widen Holmqvist L, Tollback A (2009) Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the international classification of functioning, disability and health. J Rehab Med 41:512–520
Gibbs JW 3rd, Ciafaloni E, Radtke RA (2002) Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 25:672–675
Martinez-Rodriguez JE, Lin L, Iranzo A, Genis D, Marti MJ, Santamaria J et al (2003) Decreased hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep 26:287–290
Ono S, Kurisaki H, Sakuma A, Nagao K (1995) Myotonic dystrophy with alveolar hypoventilation and hypersomnia: a clinicopathological study. J Neurol Sci 128:225–231
Thomasen E (1948) Myotonia. Aarhuus Universitetsforlaget, Denmark
Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP et al (2012) Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79:348–357
Laberge L, Dauvilliers Y, Bégin P, Richer L, Jean S, Mathieu J (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromusc Disord 19:397–402
Laberge L, Gagnon C, Jean S, Mathieu J (2005) Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability. J Neurol Neurosurg Psychiatr 76:1403–1405
Laberge L, Mathieu J, Auclair J, Gagnon E, Noreau L, Gagnon C (2013) Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol 70:308–315
Laberge L, Veillette S, Mathieu J, Auclair J, Perron M (2007) The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet 71:59–66
Gagnon C, Petitclerc E, Kierkegaard M, Mathieu J, Duchesne E, Hebert LJ (2018) A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1. J Neurol 265:1698–1705
Laberge L, Bégin P, Montplaisir J, Mathieu J (2004) Sleep complaints in patients with myotonic dystrophy. J Sleep Res 13:95–100
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123
Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull 9:13–28
Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific impairment rating scale in myotonic dystrophy. Neurology 56:336–340
Graham JW (2009) Missing data analysis: making it work in the real world. Ann Rev Psychol 60:549–576
Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G (2007) The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 62:571–579
Gliem C, Minnerop M, Roeske S, Gartner H, Schoene-Bake JC, Adler S et al (2019) Tracking the brain in myotonic dystrophies: a 5-year longitudinal follow-up study. PLoS One 14:e0213381
Hunter A, Tsilfidis C, Mettler G, Jacob P, Mahadevan M, Surh L et al (1992) The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 29:774–779
Novelli G, Gennarelli M, Menegazzo E, Mostacciuolo ML, Pizzuti A, Fattorini C et al (1993) (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol 50:85–92
Sistiaga A, Urreta I, Jodar M, Cobo AM, Emparanza J, Otaegui D et al (2010) Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. Psychol Med 40:487–495
Orngreen MC, Arlien-Soborg P, Duno M, Hertz JM, Vissing J (2012) Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol 259:912–920
Groh WJ, Lowe MR, Zipes DP (2002) Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electr 13:444–448
Melacini P, Villanova C, Menegazzo E, Novelli G, Danieli G, Rizzoli G et al (1995) Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 25:239–245
Bertrand JA, Jean S, Laberge L, Gagnon C, Mathieu J, Gagnon JF et al (2015) Psychological characteristics of patients with myotonic dystrophy type 1. Acta Neurol Scand 132:49–58
Jean S, Richer L, Laberge L, Mathieu J (2014) Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1). Orphanet J Rare Dis 9:186
Winblad S, Lindberg C, Hansen S (2006) Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2:16
Itoh K, Mitani M, Kawamoto K, Futamura N, Funakawa I, Jinnai K et al (2010) Neuropathology does not correlate with regional differences in the extent of expansion of CTG repeats in the brain with Myotonic dystrophy type 1. Acta Histochem Cytoc 43:149–156
Kuo HC, Hsieh YC, Wang HM, Chuang WL, Huang CC (2008) Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1. Acta Neurol Scand 117:101–107
Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocr Metabl 90:4510–4515
Resta O, Foschino Barbaro MP, Bonfitto P, Giliberti T, Depalo A, Pannacciulli N et al (2003) Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 253:536–543
Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A (1998) Obesity without sleep apnea is associated with daytime sleepiness. Arch Int Med 158:1333–1337
Laberge L, Dauvilliers Y (2011) Myotonic dystrophy and sleepiness. In: Thorpy M, Billiard M (eds) Sleepiness: causes, consequences, disorders and treatment. Cambridge University Press, Cambridge, pp 316–328
Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M et al (2011) Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep 34:165–170
Dahlqvist JR, Orngreen MC, Witting N, Vissing J (2015) Endocrine function over time in patients with myotonic dystrophy type 1. Eur J Neurol 22:116–122
Johnson NE, Abbott D, Cannon-Albright LA (2015) Relative risks for comorbidities associated with myotonic dystrophy: a population-based analysis. Muscle Nerve 52:659–661
Rioperez E, Botella JM, Palacio A, Abaitua I, Trueba JL, Ricoy-Campo JR (1979) Myotonic dystrophy associated with thyroid disease. J Neurol Sci 43:357–366
Steinbeck KS, Carter JN (1982) Thyroid abnormalities in patients with myotonic dystrophy. Clin Endocrinol 17:449–456
Fukazawa H, Sakurada T, Yoshida K, Kaise N, Kaise K, Nomura T et al (1990) Thyroid function in patients with myotonic dystrophy. Clin Endocrinol 32:485–490
Tredici G, Coletti A (1978) Dystrophia myotonica and hypothyroidism. J Neurol 218:215–218
Margolis J, Freitas WJ, Margolis LS (1973) Hypothyroidism mimicking myotonic dystrophy. J Am Geriatr Soc 21:31–32
Chaudhry N, Puri V, Patidar Y, Khwaja G (2016) Hypothyroidism masking myotonic dystrophy. J Indian Acad Clin Med 17:40–43
Kapica-Topczewska K, Pogorzelski R, Tarasiuk J, Drozdowski W, Lewczuk P, Kulakowska A (2017) Excessive daytime sleepiness in a patient with coexisting myotonic dystrophy type 1, myasthenia gravis and Graves’ disease. Neurol Neurochir Pol 51:190–193
Coccagna G, Mantovani M, Parchi C, Mironi F, Lugaresi E (1975) Alveolar hypoventilation and hypersomnia in myotonic dystrophy. J Neurol Neurosurg Psychiatr 38:977–984
Manni R, Zucca C, Martinetti M, Ottolini A, Lanzi G, Tartara A (1991) Hypersomnia in dystrophia myotonica: a neurophysiological and immunogenetic study. Acta Neurol Scand 84:498–502
Phemister JC, Small JM (1961) Hypersomnia in dystrophia myotonica. J Neurol Neurosurg Psychiatr 24:173–175
Phillips MF, Steer HM, Soldan JR, Wiles CM, Harper PS (1992) Daytime somnolence in myotonic dystrophy. J Neurol 246:275–282
van der Meché FG, Bogaard JM, van der Sluys HC, Schimsheimer RJ, Ververs CC, Busch HF (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatr 57:626–628
van Hilten JJ, Kerkhof GA, van Dijk JG, Dunnewold R, Wintzen AR (1993) Disruption of sleep-wake rhythmicity and daytime sleepiness in myotonic dystrophy. J Neurol Sci 114:68–75
Dauvilliers YA, Laberge L (2012) Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep Med Rev 16:539–545
Hossain JL, Ahmad P, Reinish LW, Kayumov L, Hossain NK, Shapiro CM (2005) Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res 14:245–253
Chervin RD (2000) Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 118:372–379
Dement WC (2003) Tiredness versus sleepiness: semantics or a target for public education? Sleep 26:485–486
Merkelbach S, Schulz H (2006) What have fatigue and sleepiness in common? J Sleep Res 15:105–106
Hermans MC, Merkies IS, Laberge L, Blom EW, Tennant A, Faber CG (2012) Fatigue and daytime sleepiness scale in myotonic dystrophy type 1. Muscle Nerve 47:89–95
Gagnon C, Heatwole C, Hebert LJ, Hogrel JY, Laberge L, Leone M et al (2015) Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8. J Neuromusc Dis 5:523–537